Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.
A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Trial reveals kimchi's dual action: consuming 3000 mg daily not only reduced body fat mass but also increased beneficial gut bacteria A. muciniphila while decreasing obesity-associated microbes.
A 433% oxytocin increase—not vasopressin—correlated with MDMA-induced hyponatremia, with fluid restriction preventing all cases in a controlled setting.